IDYA
Ideaya Biosciences Inc
37.40$
-1.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -375.4% | -605.4% | – | – | – | -1,737.9% | – | – | 68.4% | -832.1% | -1,145.9% | -1,844.7% | -79.8% | |
| 12.8% | 26.1% | – | – | – | 9.2% | – | – | 0.5% | 11.0% | 17.4% | 25.6% | 2.4% | |
| 65.9% | 122.3% | – | – | – | 135.5% | – | – | 5.9% | 108.4% | 221.6% | 352.2% | 29.8% | |
| -68.4% | 210.6% | – | – | – | 49.2% | – | – | 5.6% | -171.8% | 135.7% | 184.9% | 7.8% | |
| 7.5% | 21.4% | – | – | – | 15.7% | – | – | 0.0% | 3.1% | 14.7% | 20.7% | 1.4% | |
| 638.8% | -2,853.5% | – | – | – | -2,815.8% | – | – | 20.1% | -896.7% | 1,813.3% | -417.5% | 11.2% | |
| – | – | – | – | – | – | – | – | – | – | -0.1% | – | – | |
| 346.3% | 3,591.5% | – | – | – | 39.3% | – | – | 0.1% | 19.6% | 18.0% | 4,069.0% | 155.5% | |
| 609.7% | 151.0% | – | – | – | -4,514.4% | – | – | 88.7% | -1,711.1% | 681.4% | 1,806.8% | 86.7% | |
| -382.9% | -626.7% | – | – | – | -1,753.7% | – | – | 68.4% | -835.1% | -1,160.6% | -1,865.3% | -81.2% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.